Evidence map›Paper›PMID 33875847›Full record

ArticleNature microbiology2021

Genetic variation of staphylococcal LukAB toxin determines receptor tropism.

Sofya S Perelman, David B A James, Kristina M Boguslawski, Chase W Nelson, Juliana K Ilmain, Erin E Zwack, Rachel A Prescott, Adil Mohamed, Kayan Tam, Rita Chan and 12 more

Open access · greenAbstract read
In one paragraph

Article in Nature microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.0field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 20 citations in OpenAlex.

  1. Hv1 channel in immune cells and pharmacology.Pharmacological research · 2025
    Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Infection and immunity · 2024
    Article
  7. Review
  8. Article
  9. Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  10. Article
  11. Microorganisms · 2022
    Review
  12. Article
  13. Bacterial pore-forming toxins.Microbiology (Reading, England) · 2022
    Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 3 institutions in 2 countries.

Sofya S Perelman *Department of Microbiology, New York University Grossman School of Medicine, New York, NY, USA.ORCID http://orcid.org/0000-0001-9706-8156
David B A James *Department of Microbiology, New York University Grossman School of Medicine, New York, NY, USA.
Kristina M Boguslawski *Department of Microbiology, New York University Grossman School of Medicine, New York, NY, USA.
Chase W NelsonInstitute for Comparative Genomics, American Museum of Natural History, New York, NY, USA.
Juliana K IlmainDepartment of Microbiology, New York University Grossman School of Medicine, New York, NY, USA.ORCID http://orcid.org/0000-0002-9507-5069
Erin E ZwackDepartment of Microbiology, New York University Grossman School of Medicine, New York, NY, USA.
Rachel A PrescottDepartment of Microbiology, New York University Grossman School of Medicine, New York, NY, USA.
Adil MohamedDepartment of Microbiology, New York University Grossman School of Medicine, New York, NY, USA.
Kayan TamDepartment of Microbiology, New York University Grossman School of Medicine, New York, NY, USA.
Rita ChanDepartment of Microbiology, New York University Grossman School of Medicine, New York, NY, USA.
Apurva NarechaniaInstitute for Comparative Genomics, American Museum of Natural History, New York, NY, USA.
Miranda B PawlineDepartment of Microbiology, New York University Grossman School of Medicine, New York, NY, USA.
Nikollaq VozhillaDepartment of Microbiology, New York University Grossman School of Medicine, New York, NY, USA.
Ahmed M MoustafaDepartment of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0002-9949-6936
Sang Y KimDepartment of Pathology, New York University Grossman School of Medicine, New York, NY, USA.
Meike DittmannDepartment of Microbiology, New York University Grossman School of Medicine, New York, NY, USA.
Damian C EkiertDepartment of Microbiology, New York University Grossman School of Medicine, New York, NY, USA.
Gira BhabhaSkirball Institute of Biomolecular Medicine and Department of Cell Biology, New York University Grossman School of Medicine, New York, NY, USA.
Bo ShopsinDepartment of Microbiology, New York University Grossman School of Medicine, New York, NY, USA.
Paul J PlanetInstitute for Comparative Genomics, American Museum of Natural History, New York, NY, USA.
Sergei B KoralovDepartment of Pathology, New York University Grossman School of Medicine, New York, NY, USA.ORCID http://orcid.org/0000-0002-4843-3791
Victor J TorresDepartment of Microbiology, New York University Grossman School of Medicine, New York, NY, USA. Victor.Torres@nyulangone.org.ORCID http://orcid.org/0000-0002-7126-0489
New York University · USAmerican Museum of Natural History · USChildren's Hospital of Philadelphia · US

Funding

Vaccine FacilityP30CA016087 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Aristotelis Tsirigos · 1985 to 2026
$83.1M
MEDICAL SCIENTIST TRAININGT32GM007308 · NIGMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI PHILIPS, MARK REID · 1985 to 2019
$23.2M
INFECTIOUS DISEASES &BASIC MICROBIOLOGICAL MECHANISMST32AI007180 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI WEISER, JEFFREY NEAL · 1985 to 2022
$8.9M
Mechanistic Studies Of The Staphylococcus aureus LukAB CytotoxinR01AI099394 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Victor J. Torres · 2013 to 2026
$6.1M
Redefining the role of autophagy in bacterial diseaseR01AI121244 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI Ken Hashigiwa Cadwell · 2017 to 2026
$5.6M
Contribution of LukED to Staphylococcus aureus pathobiologyR01AI105129 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI TORRES, VICTOR J. · 2014 to 2023
$4.9M
Unravelling lipid trafficking for the bacterial outer membraneR35GM128777 · NIGMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Damian Ekiert · 2018 to 2026
$4.1M
Mechanisms of MRSA intestinal colonizationR01AI140754 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI SHOPSIN, BO · 2020 to 2024
$3.5M
Host-pathogen interactions during hospital adaptation of MRSAR01AI137336 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI SHOPSIN, BO, YANAI, ITAI · 2019 to 2022
$3.3M
Bacterial Interference to Prevent Staphylococcus aureus InfectionR01AI137526 · NIAID · CHILDREN'S HOSP OF PHILADELPHIA · PI PLANET, PAUL J · 2018 to 2021
$1.7M
Deciphering the cellular signals emanating from Staphylococcus aureus LukAB interaction with host-receptor that result in immune cell deathF32AI122486 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI JAMES, DAVID B.A · 2016 to 2017
$67k
NCI NIH HHS P30 CA016087NIAID NIH HHS F32 AI122486NIAID NIH HHS HHSN272201400019CNIAID NIH HHS R01 AI099394NIAID NIH HHS R01 AI105129NIAID NIH HHS R01 AI121244NIAID NIH HHS R01 AI137336NIAID NIH HHS R01 AI137526NIAID NIH HHS R01 AI140754NIAID NIH HHS T32 AI007180NIGMS NIH HHS R35 GM128777NIGMS NIH HHS T32 GM007308
6 · The paper itself

Abstract

Staphylococcus aureus has evolved into diverse lineages, known as clonal complexes (CCs), which exhibit differences in the coding sequences of core virulence factors. Whether these alterations affect functionality is poorly understood. Here, we studied the highly polymorphic pore-forming toxin LukAB. We discovered that the LukAB toxin variants produced by S. aureus CC30 and CC45 kill human phagocytes regardless of whether CD11b, the previously established LukAB receptor, is present, and instead target the human hydrogen voltage-gated channel 1 (HVCN1). Biochemical studies identified the domain within human HVCN1 that drives LukAB species specificity, enabling the generation of humanized HVCN1 mice with enhanced susceptibility to CC30 LukAB and to bloodstream infection caused by CC30 S. aureus strains. Together, this work advances our understanding of an important S. aureus toxin and underscores the importance of considering genetic variation in characterizing virulence factors and understanding the tug of war between pathogens and the host.

Indexed as

AnimalsBacterial ProteinsCD11b AntigenGenetic VariationHumansIon ChannelsLeukocidinsMiceMice, Inbred C57BLPhagocytesStaphylococcal InfectionsStaphylococcus aureusBacterial ProteinsCD11b AntigenHVCN1 protein, humanIon Channelsleukocidin AB, Staphylococcus aureusLeukocidins

Identifiers

PMID33875847
PMCPMC8597016
OpenAlexW3152707674

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.